CRL · Charles River Laboratories International, Inc. · Debt
$337.54
-2.12 (-0.62%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$16.21B
Shares
47.74M
Volume · Oct 23
18.17K
Avg daily vol (3M)
1M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Latest reported total
USD 2,100,000,000
As of Dec 27, 2025
Tracked instruments
0
Loans, facilities and note series
Annual baseline
Dec 27, 2025
Latest approved annual total
Reported total debt history
| As of | Reported label | Amount | Source |
|---|---|---|---|
| 2025-12-27 | debt and finance leases | USD 2,100,000,000 |
10-K filed 2026-02-18
As of December 27, 2025, we had $2.1 billion of debt and finance leases (debt). |
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current long-term debt and lease obligations | 2026-06-27 | USD 6,626,000 | 10-Q filed 2026-08-05 |
| Current portion of long-term debt | 2026-06-27 | USD 5,460,000 | 10-Q filed 2026-08-05 |
| Finance lease liabilities | 2026-06-27 | USD 9,848,000 | 10-Q filed 2026-08-05 |
Related accounting measures — not additional borrowingCarrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.
| |||
| Noncurrent long-term debt and lease obligations | 2026-06-27 | USD 2,619,985,000 | 10-Q filed 2026-08-05 |
| Noncurrent operating lease liabilities | 2026-06-27 | USD 407,708,000 | 10-Q filed 2026-08-05 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1100682
CUSIP
159864107
13F (30d)
107 filings
100 filers
Visit website
Investor relations